Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 6/2004

01-06-2004 | BRIEF REVIEW

The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: A view to the future from the “bench-to-bedside”

Author: Prof. Marinos C. Dalakas

Published in: Journal of Neurology | Issue 6/2004

Login to get access
Metadata
Title
The future prospects in the classification, diagnosis and therapies of inflammatory myopathies: A view to the future from the “bench-to-bedside”
Author
Prof. Marinos C. Dalakas
Publication date
01-06-2004
Publisher
Steinkopff-Verlag
Published in
Journal of Neurology / Issue 6/2004
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-004-0353-z

Other articles of this Issue 6/2004

Journal of Neurology 6/2004 Go to the issue

ORIGINAL COMMUNICATION

Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2

LETTER TO THE EDITORS

Four single nucleotide polymorphisms from the Vitamin D Receptor Gene in UK Multiple Sclerosis

LETTER TO THE EDITORS

Concomitant manifestation of primary CNS lymphoma and Toxoplasma encephalitis in a patient with AIDS

ORIGINAL COMMUNICATION

P300 and neuropsychological evaluation in Behçet’s disease with and without neurological manifestations

ORIGINAL COMMUNICATION

Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer’s disease

LETTER TO THE EDITORS

Successful treatment of steroid-refractory neurosarcoidosis with infliximab